Activity of Brigatinib in Crizotinib and Ceritinib-Resistant
ROS1-
Rearranged Non-Small-Cell Lung Cancer
JCO Precis Oncol
.
2019:3:PO.18.00267.
doi: 10.1200/po.18.00267.
Epub 2019 Feb 15.
Authors
Aparna Hegde
1
,
David S Hong
1
,
Amini Behrang
1
,
Siraj M Ali
2
,
Luke Juckett
2
,
Funda Meric-Bernstam
1
,
Vivek Subbiah
1
Affiliations
1
University of Texas MD Anderson Cancer Center, Houston, TX.
2
Foundation Medicine, Cambridge, MA.
PMID:
32775947
PMCID:
PMC7410165
DOI:
10.1200/po.18.00267
No abstract available
Grants and funding
P30 CA016672/CA/NCI NIH HHS/United States
U01 CA180964/CA/NCI NIH HHS/United States